Cargando…
COVID-19 in patients with B cell immune deficiency
This article aims to describe the clinical manifestations and management of COVID-19 in patients with primary and secondary B cell deficient states. We describe the epidemiologic and clinical features as well as unique management paradigm including isolation precautions with COVID-19. We then focus...
Autores principales: | Vergidis, Paschalis, Levy, Emily R., Ristagno, Elizabeth H., Iyer, Vivek N., O'Horo, John C., Joshi, Avni Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450485/ https://www.ncbi.nlm.nih.gov/pubmed/36087764 http://dx.doi.org/10.1016/j.jim.2022.113351 |
Ejemplares similares
-
Diagnostic Methods and Risk Factors for Severe Disease and Mortality in Blastomycosis: A Retrospective Cohort Study
por: O’Dowd, Timothy R., et al.
Publicado: (2021) -
Cavitary lung lesions caused by Pneumocystis jirovecii in setting of common variable immune deficiency
por: Zhang, Zhenmei, et al.
Publicado: (2020) -
In reply—Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
por: O’Horo, John C., et al.
Publicado: (2021) -
Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies
por: Squire, Jacqueline D., et al.
Publicado: (2021) -
COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients
por: Kasten, Mary J., et al.
Publicado: (2023)